News

Trend Structure: Textbook Sustained Uptrend — Seven-Week Bull Phase With No Structural Damage

Liquidia Corporation (NASDAQ: LQDA) delivered one of the most emphatic commercial readouts in the pulmonary hypertension space on Tuesday, sending its shares soaring 23.29 per cent to $52.15 as investors digested a first-quarter performance that left little room for equivocation. YUTREPIA, the company's inhaled …

Shares in Ensysce Biosciences (NASDAQ: ENSC) edged lower on Tuesday, falling 3.08 per cent to $0.3394, even as the company placed itself at the centre of one of the most consequential debates in contemporary pharmacology: how to engineer effective pain relief without handing patients …

Zai Lab Limited (NASDAQ: ZLAB) added 5.65 per cent on Tuesday to close at $19.65, lifted by news that the FDA has extended a second Fast Track Designation to zocilurtatug pelitecan — known within the oncology community as zoci — for the treatment of …

MoonLake Immunotherapeutics (NASDAQ: MLTX) advanced 9.38 per cent on Tuesday to $18.66, buoyed by confirmation that it has completed a productive final pre-BLA meeting with the US Food and Drug Administration for sonelokimab in hidradenitis suppurativa — a chronic, debilitating inflammatory skin condition that …

Exagen Inc. (NASDAQ: XGN) surged 25.42 per cent to $3.70 on Tuesday after the medical diagnostics company reported a first quarter that exceeded expectations on the metrics that matter most for a diagnosticsBusinessat this stage of its commercial development: volume, pricing, and the trajectory …

Zai Lab Limited (NASDAQ: ZLAB) added 5.65 per cent on Tuesday to close at $19.65, lifted by news that the FDA has extended a second Fast Track Designation to zocilurtatug pelitecan — known within the oncology community as zoci — for the treatment of …